The Collier Report of U.S. Government Contracting

Old School Reporting Using Modern Technology

Immunetics Inc

  • Contact Person: Andrew Levin
  • Contact Phone: 617-982-7445
  • Contact Email: ALEVIN@IMMUNETICS.COM
  • Business Structure:
  • Corporate Entity (Not Tax Exempt)
  • Business Type:
  • Foreign Owned and Located
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Industries Served: In-Vitro Diagnostic Substance Manufacturing, Research and Development in Biotechnology, Medical Laboratories
  • Product Areas: IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS, IN VITRO DIAGNO SUBSTANCES,REAGENTS

Sampling of Federal Government Funding Actions/Set Asides

In order by amount of set aside monies.

  • $3,667,660 - Thursday the 24th of July 2014
    National Institutes Of Health
    NIH, NHLBI, DERA OA OFC ACQUISTIONS
    IGF::OT::IGF RD-SBIR TOPIC 56 PHASE II IMMUNETICS

© Copyright 2019
The Collier Report
published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources. No reliance should be made by readers or Collier Report subscribers. Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances. Requests for the modification of displayed information may be made to help.desk@1918.media.